Yes it needs FDA approval . GSS have limited approval for their Enteric product in the US , it can be used by around 8,000 certified labs . So far there are labs trialing and assessing the product and one major lab has opted to use the product and has placed repeat orders . Other products are going though the validation process to aquire FDA approval . I would hope once the FDA fully appreciates the tech they will pass future products without major scrutiny but we are talking about the FDA here . I think the EU and Australian markets are the short term goals it seems the EU are more willing to accept new / better tech . I do think as I have stated in previous posts once GSS obtains more EU /US approvals one of the big players will try to aquire GSS . This tech is the future in pathology industry and the major players won’t want to be left behind .
- Forums
- ASX - By Stock
- GSS
- Ann: Update to major customer contract announcement
Ann: Update to major customer contract announcement, page-7
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GSS (ASX) to my watchlist
(20min delay)
|
|||||
Last
67.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $155.4M |
Open | High | Low | Value | Volume |
70.0¢ | 70.0¢ | 67.5¢ | $8.472K | 12.18K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 29814 | 67.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
69.5¢ | 900 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 0.710 |
2 | 10880 | 0.680 |
1 | 100000 | 0.650 |
1 | 1627 | 0.615 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.740 | 15725 | 2 |
0.750 | 22017 | 2 |
0.760 | 39008 | 2 |
0.800 | 500 | 1 |
0.810 | 40999 | 1 |
Last trade - 11.38am 03/12/2024 (20 minute delay) ? |
GSS (ASX) Chart |